Table IV.
Outcome | Comparison | MD or RR [95% CrI] |
---|---|---|
Pain score (0-100) at ≤4 wk | ESIN vs. F8B | MD, 0.61 [−11.75 to 12.77] |
ESIN vs. plate | MD, 9.49 [−2.53 to 21.63] | |
ESIN vs. sling | MD, 2.09 [−11.99 to 16.18] | |
F8B vs. plate | MD, 8.91 [−1.09 to 18.86] | |
F8B vs. sling | MD, 1.45 [−7.85 to 11.33] | |
Plate vs. sling | MD, −7.42 [−17.4 to 3.17] | |
Pain score (0-100) at 6 wk | ESIN vs. F8B | MD, −9.18 [−42.54 to 24.17] |
ESIN vs. plate | MD, 3.07 [−30.08 to 36.55] | |
ESIN vs. sling | MD, 3.14 [−46.86 to 52.71] | |
F8B vs. plate | MD, 12.36 [−8.65 to 33.27] | |
F8B vs. sling | MD, 12.31 [−30.14 to 54.83] | |
Plate vs. sling | MD, 0.05 [−36.96 to 36.81] | |
Pain score (0-100) at 12 wk | ESIN vs. F8B | MD, −1.04 [−25.69 to 23.38] |
ESIN vs. plate | MD, 6.03 [−18.98 to 30.30] | |
ESIN vs. sling | MD, 4.67 [−25.81 to 34.93] | |
F8B vs. plate | MD, 7.09 [−7.63 to 21.26] | |
F8B vs. sling | MD, 5.71 [−14.61 to 26.08] | |
Plate vs. sling | MD, −1.32 [−21.51 to 18.99] | |
Pain score (0-100) at 24 wk | ESIN vs. F8B | MD, −5.60 [−20.91 to 9.60] |
ESIN vs. plate | MD, −1.46 [−16.74 to 13.55] | |
F8B vs. plate | MD, 4.14 [−5.03 to 13.16] | |
Pain score (0-100) at 52 wk | ESIN vs. F8B | MD, −2.78 [−10.79 to 5.34] |
ESIN vs. plate | MD, −3.29 [−11.24 to 4.88] | |
ESIN vs. sling | MD, −7.26 [−18.80 to 4.32] | |
F8B vs. plate | MD, −0.51 [−5.25 to 4.23] | |
F8B vs. sling | MD, −4.49 [−14.19 to 5.22] | |
Plate vs. sling | MD, −3.95 [−12.41 to 4.52] | |
Pain score (0-100) at >52 wk | ESIN vs. plate | MD, −9.98 [−23.86 to 4.04] |
ESIN vs. sling | MD, −7.96 [−26.96 to 10.83] | |
Plate vs. sling | MD, 2.00 [−11.11 to 14.97] | |
Function score (0-100) at ≤4 wk | ESIN vs. F8B | MD, 5.40 [−23.72 to 34.69] |
ESIN vs. IMP | MD, 15.17 [−30.04 to 60.34] | |
ESIN vs. plate | MD, −2.72 [−24.36 to 20.11] | |
ESIN vs. sling | MD, 28.63 [−2.71 to 60.30] | |
F8B vs. IMP | MD, 9.70 [−44.29 to 63.45] | |
F8B vs. plate | MD, −8.04 [−36.92 to 21.63] | |
F8B vs. sling | MD, 23.21 [−20.15 to 66.15] | |
IMP vs. plate | MD, −17.86 [−67.07 to 32.03] | |
IMP vs. sling | MD, 13.39 [−19.27 to 46.33] | |
Plate vs. sling | MD, 31.33 [−7.71 to 69.54] | |
Function score (0-100) at 6 wk | CRx vs. ESIN | MD, 9.46 [−12.59 to 30.83] |
CRx vs. F8B | MD, 17.05 [−7.41 to 41.30] | |
CRx vs. F8B + sling | MD, 17.93 [−7.07 to 42.87] | |
CRx vs. IMP | MD, 10.36 [−20.38 to 40.70] | |
CRx vs. plate | MD, 11.04 [−9.78 to 31.58 ] | |
CRx vs. sling | MD, 20.16 [−1.61 to 42.08] | |
ESIN vs. F8B | MD, 7.67 [−6.13 to 21.53] | |
ESIN vs. F8B + sling | MD, 8.54 [−7.37 to 24.26] | |
ESIN vs. IMP | MD, 0.87 [−22.86 to 24.60] | |
ESIN vs. plate | MD, 1.60 [−5.31 to 8.51] | |
ESIN vs. sling∗ | MD, 10.73 [1.21 to 20.35] | |
F8B vs. F8B + sling | MD, 0.90 [−18.47 to 20.27] | |
F8B vs. IMP | MD, −6.72 [−32.91 to 19.45] | |
F8B vs. plate | MD, −6.07 [−19.06 to 7.05] | |
F8B vs. sling | MD, 3.09 [−11.74 to 17.99] | |
F8B + sling vs. IMP | MD, −7.54 [−34.40 to 19.18] | |
F8B + sling vs. plate | MD, −6.91 [−21.04 to 7.39] | |
F8B + sling vs. sling | MD, 2.23 [−13.68 to 18.32] | |
IMP vs. plate | MD, 0.69 [−22.26 to 23.48] | |
IMP vs. sling | MD, 9.79 [−11.73 to 31.50] | |
Plate vs. sling∗ | MD, 9.12 [1.66 to 16.66] | |
Function score (0-100) at 12 wk | CRx vs. ESIN | MD, 7.88 [−5.32 to 21.12] |
CRx vs. F8B∗ | MD, 14.89 [0.22 to 29.65] | |
CRx vs. F8B + sling∗ | MD, 17.86 [1.07 to 34.49] | |
CRx vs. IMP | MD, 5.16 [−16.23 to 26.52] | |
CRx vs. plate | MD, 9.98 [−2.42 to 22.53] | |
CRx vs. sling | MD, 12.88 [−0.16 to 26.24] | |
ESIN vs. F8B | MD, 7.07 [−1.27 to 15.43] | |
ESIN vs. F8B + sling | MD, 9.96 [−1.83 to 21.96] | |
ESIN vs. IMP | MD, −2.66 [−20.27 to 15.17] | |
ESIN vs. plate | MD, 2.12 [−2.25 to 6.65] | |
ESIN vs. sling | MD, 5.03 [−0.49 to 10.74] | |
F8B vs. F8B + sling | MD, 2.92 [−10.79 to 16.62] | |
F8B vs. IMP | MD, −9.74 [−28.31 to 8.90] | |
F8B vs. plate | MD, −4.95 [−12.88 to 3.11] | |
F8B vs. sling | MD, −2.03 [−9.98 to 5.98] | |
F8B + sling vs. IMP | MD, −12.63 [−33.22 to 7.97] | |
F8B + sling vs. plate | MD, −7.82 [−18.99 to 3.37] | |
F8B + sling vs. sling | MD, −4.90 [−16.65 to 6.84] | |
IMP vs. plate | MD, 4.79 [−12.59 to 22.03] | |
IMP vs. sling | MD, 7.69 [−9.03 to 24.55] | |
Plate vs. sling | MD, 2.91 [−1.16 to 7.01] | |
Function score (0-100) at 24 wk | CRx vs. ESIN | MD, 8.01 [−1.56 to 17.68] |
CRx vs. F8B∗ | MD, 14.65 [4.70 to 24.79] | |
CRx vs. F8B + sling∗ | MD, 13.39 [2.04 to 24.53] | |
CRx vs. IMP∗ | MD, 12.18 [1.16 to 23.34] | |
CRx vs. plate∗ | MD, 9.99 [0.87 to 19.27] | |
CRx vs. sling∗ | MD, 14.59 [4.97 to 24.49] | |
ESIN vs. F8B∗ | MD, 6.65 [1.90 to 11.39] | |
ESIN vs. F8B + sling | MD, 5.35 [−1.74 to 12.25] | |
ESIN vs. IMP | MD, 4.13 [−2.53 to 10.96] | |
ESIN vs. plate | MD, 1.97 [−0.81 to 4.79] | |
ESIN vs. sling∗ | MD, 6.58 [2.60 to 10.65] | |
F8B vs. F8B + sling | MD, −1.30 [−9.04 to 6.16] | |
F8B vs. IMP | MD, −2.54 [−9.93 to 4.96] | |
F8B vs. plate∗ | MD, −4.68 [−8.75 to −0.57] | |
F8B vs. sling | MD, −0.09 [−5.19 to 5.14] | |
F8B + sling vs. IMP | MD, −1.23 [−10.03 to 7.92] | |
F8B + sling vs. plate | MD, −3.37 [−9.63 to 3.24] | |
F8B + sling vs. sling | MD, 1.22 [−5.77 to 8.52] | |
IMP vs. plate | MD, −2.14 [−8.40 to 4.00] | |
IMP vs. sling | MD, 2.47 [−3.93 to 8.84] | |
Plate vs. sling∗ | MD, 4.60 [1.45 to 7.86] | |
Function score (0-100) at 52 wk | CRx vs. ESIN | MD, 2.53 [−3.42 to 8.43] |
CRx vs. F8B | MD, 4.27 [−2.62 to 11.20] | |
CRx vs. IMP | MD, 3.52 [−3.48 to 10.63] | |
CRx vs. plate | MD, 2.84 [−2.01 to 7.70] | |
CRx vs. sling∗ | MD, 5.82 [0.31 to 11.47] | |
ESIN vs. F8B | MD, 1.72 [−3.81 to 7.37] | |
ESIN vs. IMP | MD, 0.99 [−5.07 to 7.08] | |
ESIN vs. plate | MD, 0.28 [−3.00 to 3.74] | |
ESIN vs. sling | MD, 3.29 [−0.87 to 7.67] | |
F8B vs. IMP | MD, −0.72 [−7.68 to 6.28] | |
F8B vs. plate | MD, −1.42 [−6.36 to 3.55] | |
F8B vs. sling | MD, 1.56 [−3.55 to 6.85] | |
IMP vs. plate | MD, −0.70 [−5.72 to 4.34] | |
IMP vs. sling | MD, 2.30 [−2.89 to 7.61] | |
Plate vs. sling∗ | MD, 3.00 [0.33 to 5.73] | |
Function score (0-100) at >52 wk | ESIN vs. F8B | MD, 0.98 [−12.32 to 14.47] |
ESIN vs. IMP | MD, −0.85 [−9.71 to 8.16] | |
ESIN vs. plate | MD, 0.11 [−2.43 to 2.92] | |
ESIN vs. sling∗ | MD, 4.75 [1.56 to 8.04] | |
F8B vs. IMP | MD, −1.85 [−11.78 to 8.15] | |
F8B vs. plate | MD, −0.82 [−14.06 to 12.27] | |
F8B vs. sling | MD, 3.81 [−9.82 to 17.15] | |
IMP vs. plate | MD, 0.99 [−7.46 to 9.57] | |
IMP vs. sling | MD, 5.63 [−3.47 to 14.56] | |
Plate vs. sling∗ | MD, 4.63 [1.56 to 7.54] | |
Time to radiographic union, wk | CRx vs. ESIN | MD, −4.50 [−10.33 to 1.61] |
CRx vs. F8B∗ | MD, −10.44 [−19.73 to −1.04] | |
CRx vs. IMP | MD, −4.73 [−12.23 to 2.78] | |
CRx vs. plate | MD, −5.38 [−10.73 to 0.00] | |
CRx vs. sling∗ | MD, −11.37 [−17.79 to −4.73] | |
ESIN vs. F8B | MD, −5.96 [−14.21 to 1.94] | |
ESIN vs. IMP | MD, −0.24 [−6.32 to 5.51] | |
ESIN vs. plate | MD, −0.89 [−3.63 to 1.63] | |
ESIN vs. sling∗ | MD, −6.88 [−10.55 to −3.27] | |
F8B vs. IMP | MD, 5.70 [−3.50 to 14.86] | |
F8B vs. plate | MD, 5.08 [−2.54 to 12.69] | |
F8B vs. sling | MD, −0.91 [−9.22 to 7.71] | |
IMP vs. plate | MD, −0.63 [−5.89 to 4.61] | |
IMP vs. sling∗ | MD, −6.62 [−12.93 to −0.05] | |
Plate vs. sling∗ | MD, −5.99 [−9.67 to −2.15] | |
Time to return to work, wk | ESIN vs. F8B | MD, −2.80 [−6.16 to 0.37] |
ESIN vs. plate | MD, −1.30 [−4.04 to 1.48] | |
ESIN vs. sling | MD, −2.44 [−5.77 to 0.76] | |
F8B vs. plate | MD, 1.49 [−0.64 to 3.90] | |
F8B vs. sling | MD, 0.35 [−2.16 to 3.00] | |
Plate vs. sling | MD, −1.14 [−3.10 to 0.71] | |
Delayed union | CRx vs. ESIN | RR, 1.21 [0.00 to 473] |
CRx vs. F8B | RR, 1.63 [0.00 to 1097] | |
CRx vs. IMP | RR, 0.41 [0.00 to 270] | |
CRx vs. plate | RR, 2.80 [0.02 to 523] | |
CRx vs. sling | RR, 1.30 [0.01 to 408] | |
ESIN vs. F8B | RR, 1.34 [0.03 to 183] | |
ESIN vs. IMP | RR, 0.34 [0.00 to 50] | |
ESIN vs. plate | RR, 2.32 [0.11 to 81] | |
ESIN vs. sling | RR, 1.06 [0.08 to 22] | |
F8B vs. IMP | RR, 0.25 [0.00 to 40] | |
F8B vs. plate | RR, 1.77 [0.03 to 50] | |
F8B vs. sling | RR, 0.81 [0.01 to 37] | |
IMP vs. plate | RR, 6.82 [0.13 to 804] | |
IMP vs. sling | RR, 3.11 [0.06 to 463] | |
Plate vs. sling | RR, 0.46 [0.04 to 5.15] | |
Malunion | ESIN vs. F8B + sling∗ | RR, 0.11 [0.00 to 0.93] |
ESIN vs. IMP | RR, 1.09 [0.16 to 6.30] | |
ESIN vs. plate | RR, 2.27 [0.84 to 6.11] | |
ESIN vs. sling | RR, 0.59 [0.21 to 1.65] | |
F8B + sling vs. IMP | RR, 10 [0.83 to 395] | |
F8B + sling vs. plate∗ | RR, 20 [3.19 to 679] | |
F8B + sling vs. sling | RR, 5.40 [0.75 to 183] | |
IMP vs. plate | RR, 2.08 [0.46 to 11] | |
IMP vs. sling | RR, 0.54 [0.11 to 3.32] | |
Plate vs. sling∗ | RR, 0.26 [0.14 to 0.49] | |
Nonunion | ESIN vs. F8B∗ | RR, 0.26 [0.06 to 0.91] |
ESIN vs. F8B + sling∗ | RR, 0.00 [0.00 to 0.13] | |
ESIN vs. IMP | RR, 0.69 [0.20 to 2.18] | |
ESIN vs. plate | RR, 1.67 [0.89 to 3.39] | |
ESIN vs. sling∗ | RR, 0.38 [0.19 to 0.79] | |
F8B vs. F8B + sling∗ | RR, 0.00 [0.00 to 0.51] | |
F8B vs. IMP | RR, 2.66 [0.63 to 13] | |
F8B vs. plate∗ | RR, 6.36 [2.18 to 24] | |
F8B vs. sling | RR, 1.46 [0.46 to 5.78] | |
IMP vs. F8B + sling∗ | RR, 0.00 [0.00 to 0.18] | |
Plate vs. F8B + sling∗ | RR, 0.00 [0.00 to 0.08] | |
Sling vs. F8B + sling∗ | RR, 0.00 [0.00 to 0.34] | |
IMP vs. plate | RR, 2.41 [0.96 to 6.89] | |
IMP vs. sling | RR, 0.55 [0.20 to 1.68] | |
Plate vs. sling∗ | RR, 0.23 [0.15 to 0.35] | |
Refracture | ESIN vs. IMP | RR, 1.73 [0.13 to 32] |
ESIN vs. plate | RR, 1.03 [0.23 to 5.87] | |
ESIN vs. sling | RR, 2.77 [0.38 to 37] | |
IMP vs. plate | RR, 0.59 [0.06 to 5.42] | |
IMP vs. sling | RR, 1.60 [0.15 to 21] | |
Plate vs. sling | RR, 2.69 [0.56 to 20] | |
Revision | ESIN vs. F8B | RR, 3.16 [0.29 to 104] |
ESIN vs. IMP | RR, 0.17 [0.00 to 2.44] | |
ESIN vs. plate | RR, 1.09 [0.37 to 3.35] | |
ESIN vs. sling | RR, 0.83 [0.23 to 2.90] | |
F8B vs. IMP | RR, 0.05 [0.00 to 1.60] | |
F8B vs. plate | RR, 0.34 [0.01 to 3.86] | |
F8B vs. sling | RR, 0.26 [0.01 to 3.07] | |
IMP vs. plate | RR, 6.30 [0.61 to 189] | |
IMP vs. sling | RR, 4.72 [0.40 to 144] | |
Plate vs. sling | RR, 0.76 [0.38 to 1.37] | |
Symptoms | CRx vs. ESIN | RR, 0.32 [0.00 to 58] |
CRx vs. F8B | RR, 0.90 [0.00 to 245] | |
CRx vs. IMP | RR, 0.86 [0.00 to 118] | |
CRx vs. plate | RR, 0.43 [0.00 to 46] | |
CRx vs. sling | RR, 2.04 [0.01 to 608] | |
ESIN vs. F8B | RR, 2.80 [0.07 to 145] | |
ESIN vs. IMP | RR, 2.69 [0.17 to 46] | |
ESIN vs. plate | RR, 1.35 [0.13 to 14] | |
ESIN vs. sling | RR, 6.30 [0.22 to 372] | |
F8B vs. IMP | RR, 0.96 [0.04 to 20] | |
F8B vs. plate | RR, 0.48 [0.02 to 9.49] | |
F8B vs. sling | RR, 2.24 [0.05 to 193] | |
IMP vs. plate | RR, 0.50 [0.11 to 2.20] | |
IMP vs. sling | RR, 2.31 [0.13 to 85] | |
Plate vs. sling | RR, 4.62 [0.38 to 121] |
MD, mean difference; RR, risk ratio; CrI, credible interval; ESIN, elastic stable intramedullary nail; F8B, figure-of-eight bandage; CRx, Sonoma CRx intramedullary nail; IMP, intramedullary pin.
Statistically significant.